Bosentan in Myocardium Metabolism and Perfusion Measured by 18F-FDG and 82Rb PET/CT on PAH and CTEPH
Stopped Slow patient recruitment after arrival of macitentan on the market
Conditions
- Myocardial Dysfunction
- Endothelial Dysfunction
Sponsor
University of Lausanne Hospitals